Targeting of Injectable Drug Nanocrystals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting of Injectable Drug Nanocrystals

Published:2014-04-25 Issue:6 Volume:11 Page:1762-1771
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Fuhrmann Kathrin¹,Gauthier Marc A.²,Leroux Jean-Christophe¹

Affiliation:

1. Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich (ETH Zürich), Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland

2. Institut National de la Recherche Scientifique, Énergie Matériaux Télécommunication Research Center (INRS-EMT), 1650 Boulevard Lionel-Boulet, Varennes J3X 1S2, Canada

Funder

Swiss National Science Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp5001247

Reference76 articles.

1. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

2. Stereocomplex Block Copolymer Micelles: Core−Shell Nanostructures with Enhanced Stability

3. Biodegradable polymeric nanoparticles as drug delivery devices

4. Doxil® — The first FDA-approved nano-drug: Lessons learned

5. Paclitaxel and its formulations

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting the preparation of nanocrystals: characterization, surface modifications and toxicity aspects;Expert Opinion on Drug Delivery;2023-05-26

2. A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives;RSC Advances;2023

3. Nanocrystals as a versatile platform for theranostic applications;Advanced Nanoformulations;2023

4. Size optimization of carfilzomib nanocrystals for systemic delivery to solid tumors;Journal of Controlled Release;2022-12

5. Stabilizer-induced different in vivo behaviors for intramuscularly long-acting celecoxib nanocrystals;International Journal of Pharmaceutics;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3